Strong vaccines

Pfizer-BioNTech, Moderna COVID-19 Vaccines Likely Provide "Vast Majority" Of Recipients With Long-Term Immunity, Researchers Say

The New York Times (6/28, Mandavilli) reports a new studypublished in Nature has found the COVID-19 vaccines from Pfizer-BioNTech and Moderna "set off a persistent immune reaction in the body that may protect against the coronavirus for years, scientists reported on Monday." Researchers gathered samples from the lymph nodes of 14 recruits at five different points following the first dose, finding "the number of memory cells that recognized the coronavirus had not declined" 15 weeks later. The Times adds, "The results suggest that a vast majority of vaccinated people will be protected over the long term."

        In a separate article, the New York Times (6/28, Mandavilli, Zimmer, Robbins) says the study adds to other research suggesting that "widely used vaccines will continue to protect people against the coronavirus for long periods, possibly for years, and can be adapted to fortify the immune system still further if needed."

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.